Authors
Irem Mesci, Cigdem Soydal
Published in
Magnetic resonance imaging clinics of North America. Volume 35. Issue 1. Pages 135-143. Epub Oct 23, 2026.
Abstract
Carcinoma of unknown primary (CUP) is a heterogeneous group of malignancies in which metastatic disease is histopathologically confirmed but the primary tumor site cannot be identified despite comprehensive clinical, laboratory, and imaging investigations. F18-fluorodeoxyglucose (FDG) PET/computed tomography (CT) provides whole-body metabolic imaging and may identify primary tumors and additional metastatic disease not detected by conventional imaging. PET/MR imaging combines metabolic information with the superior soft-tissue contrast of MR imaging and may provide additional diagnostic value in selected patients. Recently, fibroblast activation protein inhibitor PET/CT has emerged as a promising imaging approach for CUP, particularly in tumors with low FDG avidity.
PMID:
43039495
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0